Commentary on 'Multicentre service evaluation of injectable cabotegravir and rilpivirine delivery and outcomes across 12 UK clinics (SHARE LAI-net)'

HIV Med. 2024 Oct;25(10):1177-1178. doi: 10.1111/hiv.13689. Epub 2024 Aug 1.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anti-HIV Agents* / administration & dosage
  • Anti-HIV Agents* / therapeutic use
  • Diketopiperazines
  • HIV Infections* / drug therapy
  • Humans
  • Injections
  • Pyridones* / administration & dosage
  • Pyridones* / therapeutic use
  • Rilpivirine* / administration & dosage
  • Rilpivirine* / therapeutic use
  • Treatment Outcome
  • United Kingdom

Substances

  • cabotegravir
  • Rilpivirine
  • Pyridones
  • Anti-HIV Agents
  • Diketopiperazines